(Albany, US) DelveInsight has launched a new report on “Binge (Eating) Disorders – Market Insights, Epidemiology, and Market Forecast-2030”
DelveInsight’s “Binge (Eating) Disorders – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Binge (Eating) Disorders, historical and forecasted epidemiology as well as the Binge (Eating) Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the facts:
Scope of the Report
Request for free sample Report: https://www.delveinsight.com/sample-request/binge-eating-disorders-market
Binge-eating disorder is a serious eating disorder in which you frequently consume unusually large amounts of food and feel unable to stop eating.
Almost everyone overeats on occasion, such as having seconds or thirds of a holiday meal. But for some people, excessive overeating that feels out of control and becomes a regular occurrence crosses the line to binge-eating disorder.
When you have binge-eating disorder, you may be embarrassed about overeating and vow to stop. But you feel such a compulsion that you can’t resist the urges and continue binge eating. If you have binge-eating disorder, treatment can help.
Symptoms
Most people with binge-eating disorder are overweight or obese, but you may be at a normal weight. Behavioral and emotional signs and symptoms of binge-eating disorder include:
List of top key players in binge eating disorder drug market report are: –
● Roche
● Chronos Therapeutics
● Heptares
● Novo Nordisk
● Omeros Corp
● Sunovion Pharmaceuticals
● Opiant Pharmaceuticals
Table of Contents:
1. Key Insights
2. Executive Summary of Binge (Eating) Disorders
3. Competitive Intelligence Analysis for Binge (Eating) Disorders
4. Binge (Eating) Disorders: Market Overview at a Glance
4.1. Binge (Eating) Disorders Total Market Share (%) Distribution in 2017
4.2. Binge (Eating) Disorders Total Market Share (%) Distribution in 2030
5. Binge (Eating) Disorders: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Binge (Eating) Disorders Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Binge (Eating) Disorders Epidemiology Scenario in the 7MM (2017-2030)
7.4. United States Epidemiology
7.4.1. Binge (Eating) Disorders Epidemiology Scenario in the United States (2017-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Binge (Eating) Disorders Epidemiology Scenario in Germany (2017-2030)
7.5.2. France Epidemiology
7.5.2.1. Binge (Eating) Disorders Epidemiology Scenario in France (2017-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Binge (Eating) Disorders Epidemiology Scenario in Italy (2017-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Binge (Eating) Disorders Epidemiology Scenario in Spain (2017-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Binge (Eating) Disorders Epidemiology Scenario in the United Kingdom (2017-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Binge (Eating) Disorders Epidemiology Scenario in Japan (2017-2030)
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Binge (Eating) Disorders Treatment and Management
8.2. Binge (Eating) Disorders Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Binge (Eating) Disorders Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
List to be continued in report
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
13. Binge (Eating) Disorders: Seven Major Market Analysis
13.1. Key Findings
13.2. Binge (Eating) Disorders Market Size in 7MM
13.3. Binge (Eating) Disorders Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Binge (Eating) Disorders Total Market Size in the United States
15.1.2. Binge (Eating) Disorders Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Binge (Eating) Disorders Total Market Size in Germany
15.3.2. Binge (Eating) Disorders Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Binge (Eating) Disorders Total Market Size in France
15.4.2. Binge (Eating) Disorders Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Binge (Eating) Disorders Total Market Size in Italy
15.5.2. Binge (Eating) Disorders Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Binge (Eating) Disorders Total Market Size in Spain
15.6.2. Binge (Eating) Disorders Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Binge (Eating) Disorders Total Market Size in the United Kingdom
15.7.2. Binge (Eating) Disorders Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Binge (Eating) Disorders Total Market Size in Japan
15.8.3. Binge (Eating) Disorders Market Size by Therapies in Japan
16. Access and Reimbursement Overview of Binge (Eating) Disorders
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/binge-eating-disorders-market?utm_source=Pressrelease&utm_medium=Pressrelease&utm_campaign=Pressrelease